Gaudium IVF & Women Health Limited logo

IPO details · Updated

Gaudium IVF & Women Health Limited

ClosedMainboardNSE: GAUDIUMBSE: GAUDIUM
Price Band
₹75 – ₹79
Lot Size
189 shares
Min. Investment
₹14,931
Issue Size
₹165 Cr
Offer Dates
20 Feb – 24 Feb 2026
Listing
27 Feb 2026

Issue Details

Full details →
Total Issue Size
₹165 Cr
2,08,86,200 shares
Fresh Issue
₹90 Cr
1,13,92,500 shares
Offer for Sale
₹75 Cr
94,93,700 shares
Face Value
₹5 per share
Issue Type
Book-built IPO
Listing At
NSE, BSE
Shares Pre-Issue
6,13,94,384
Shares Post-Issue
7,27,86,884

IPO Timeline

  1. Offer opens

    20 Feb 2026

  2. Offer closes

    24 Feb 2026

  3. Allotment

    25 Feb 2026

  4. Listing

    27 Feb 2026

Issue Allocation

Share of the offer reserved for each investor category

  • Anchor30.0%62,65,860 shares
  • QIB20.0%41,77,240 shares
  • HNI15.0%31,32,930 shares
  • Retail35.0%73,10,170 shares

Subscription Status

Times subscribed by investor category

CategoryOfferedBidsSubscribed
QIB41,77,2402,646
0.00x
HNI31,32,93028,51,821
0.91x
Retail73,10,1701,04,23,161
1.43x
Total1,46,20,3401,32,77,628
0.91x

Lot Size & Investment

1 lot = 189 shares

ApplicationLotsSharesAmount
Retail1189₹14,931
Small HNI (S-HNI)142,646₹2,09,034
Big HNI (B-HNI)6712,663₹10,00,377

Financial Performance

Restated figures in ₹ crore, unless stated otherwise

Financial performance by period
PeriodSep-25Mar-25Mar-24Mar-23
Assets106.6288.5151.0136.63
Total Income49.7570.9648.1544.26
Profit After Tax12.5119.1310.3213.53
EBITDA18.9528.6319.2720.07
Net Worth58.8546.326.9922.73
Reserves & Surplus28.1615.62621.74
Total Borrowing22.5118.9315.739.78

Key Performance Indicators

Key performance indicators
PeriodSep-25Mar-25Mar-24Mar-23
EPS (₹)2.043.121.682.2
P/E (pre-issue)25.36
P/E (post-issue)22.99

Peer Comparison

Listed companies in the same business

CompanyCMPP/EROE
Progyny Inc₹2,099.9841.5612.9%
Inspire IVF Public Company Limited₹1.9911.433.97%

About Gaudium IVF & Women Health Limited

Gaudium IVF & Women Health Limited provides IVF and women healthcare services across India through a hub-and-spoke model.

Objects of the Issue

  • Expansion of IVF centres
  • Investment in medical technology
  • Working capital requirements
  • General corporate purposes

Company Information

Strengths (from RHP)

  • Patient-centric pricing approach
  • Strong brand positioning and trust
  • Focus on medical tourism

Key risks (from RHP)

  • Operational and medical risks
  • Related party transaction risks
  • Dependence on limited embryologists
Book running lead managers
  • Sarthi Capital Advisors Private Limited
Registered office
B1/51, Janak Puri, B-1, New Delhi 110058

Disclaimer: Data on OpenIPO is for information only and is not investment advice. OpenIPO is not a SEBI-registered entity. GMP figures are unofficial estimates and may change. Verify all details against the company RHP and the official registrar before investing.